Browse > Article

UNDERSTANDING OF EPIGENETICS AND DNA METHYLATION  

Oh, Jung-Hwan (Dept. of Oral & Maxillofacial Surgery, Kyung-Hee University Dental School)
Kwon, Young-Dae (Dept. of Oral & Maxillofacial Surgery, Kyung-Hee University Dental School)
Yoon, Byung-Wook (Dept. of Oral & Maxillofacial Surgery, Kyung-Hee University Dental School)
Choi, Byung-Jun (Dept. of Oral & Maxillofacial Surgery, Kyung-Hee University Dental School)
Publication Information
Maxillofacial Plastic and Reconstructive Surgery / v.30, no.3, 2008 , pp. 302-309 More about this Journal
Abstract
Epigenetic is usually referring to heritable traits that do not involve changes to the underlying DNA sequence. DNA methylation is known to serve as cellular memory. and is one of the most important mechanism of epigenetic. DNA methylation is a covalent modification in which the target molecules for methylation in mammalian DNA are cytosine bases in CpG dinucleotides. The 5' position of cytosine is methylated in a reaction catalyzed by DNA methyltransferases; DNMTl, DNMT3a, and DNMT3b. There are two different regions in the context of DNA methylation: CpG poor regions and CpG islands. The intergenic and the intronic region is considered to be CpG poor, and CpG islands are discrete CpG-rich regions which are often found in promoter regions. Normally, CpG poor regions are usually methylated whereas CpG islands are generally hypomethylated. DNA methylation is involved in various biological processes such as tissue-specific gene expression, genomic imprinting, and X chromosome inactivation. In general. cancer cells are characterized by global genomic hypomethylation and focal hypermethylation of CpG islands, which are generally unmethylated in normal cells. Gene silencing by CpG hypermethylation at the promotors of tumor suppressor genes is probably the most common mechanism of tumor suppressor inactivation in cancer.
Keywords
Epigenetic; DNA methylation; CpG islands; Gene silencing;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Galvan-Nanso M, Campistol J, Conill J et al : Analysis of the characteristics of epilepsy in 37 pateints with the molecular diagnosis of Angelman syndrome. Epileptic Disod 7 : 19, 2005
2 Haig D, Graham C : Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 22 : 1045, 1991
3 Okada H, Kimura MT, Tan D : Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas. Int J Oncol 26 : 369, 2005   PUBMED
4 Smith IM, Mydlarz WK, Nithani SK : DNA global hypomethylation in squamouse cell head and neck cancer associated with smoking, alcohol comsumption and stage. Int J Cancer 15 : 1724, 2007
5 Bai AH, Tong JH, To KF et al : Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 112 : 846, 2004   DOI   ScienceOn
6 Viswanathan M, Tsuchida N, Shanmugam G : Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 105 : 41, 2003   DOI   ScienceOn
7 Maruya SI, Issa JP, Weber RS et al : Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10 : 3825, 2004   DOI   ScienceOn
8 Takai D, Jones PA : Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99 : 3740, 2002
9 Gronbaek K, Hother C, Jones PA : Epigenetic changes in cancer. APMIS 115 : 1030, 2007
10 Cheng MK, Disteche CM : Silence of the fathers: early X inactivation. BioEssays 26(8) : 821, 2004   DOI   ScienceOn
11 Heard E, Rougenulle C, Arnaud D et al : Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107 : 727, 2001   DOI   ScienceOn
12 Temple IK : Imprinting in human disease with special reference to transient neonatal diabetes and Beckwith- Wiedemann syndrome. Endocr Dev 12 : 113, 2007   PUBMED
13 Riggs AD, Jones PA : S-methylcytosine, gene regulation, and cancer. Adv Cancer Res 40 : 1, 1983   DOI
14 Hong SH, Kim HG, Chung WB et al : DNA hypermethylation of tumor-related genes in gastric carcinoma. J Kor Med Sci 20 : 236, 2005   DOI   ScienceOn
15 Weissbach A : A chronicle of DNA methylation.(1948- 1975). EXS 64 : 1, 1993   PUBMED
16 Heard E, Clerc P, Avner P : X-chromosome inactivation in mammals. Annu Rev Genet 31 : 571, 1997   DOI   ScienceOn
17 Ogishima T, Shiina H, Breault JE : Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene 24 : 6765, 2005   DOI   ScienceOn
18 KH Kang : Epigenetics;Understandings about DNA methylation in carcinogenesis. KMB Co. 2007
19 Yeo W, Wong WL, Wong N et al : High frequency of promoter hypermethylation of RASSF1A in tumorous and non-tumourous tissue of breast cancer. Pathology 37 : 125, 2005   DOI   ScienceOn
20 Ohhata T, Hoki Y, Sasaki H et al : Tsix-deficient X chromosome does not undergo inactivation in the embryonic lineage in male: impliations for Tsix-independent silencing of Xist. Cytogeniet Genome Res 113 : 345, 2006   DOI   ScienceOn
21 Reik W, Walter J : Genomic imprinting: parental influence on the genome. Nat Rev Genet 2 : 21, 2001   PUBMED
22 Plath K, Mlynareczyk-Evans S, Nusinow D et al : Xist RNA and the mechanism of X chromosome inactivation. Annu Rev Genet 36 : 233, 2002   DOI   ScienceOn
23 Higashimoto K, Soejima H, Saito T et al : Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. Cytogenet Genome Res 113 : 306, 2006   DOI   ScienceOn
24 Johns PA, Baylin SB : The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 : 415, 2002   DOI   PUBMED
25 Marsit CJ, Kim DH, Liu M et al : Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. Int J Cancer 114 : 219, 2005   DOI   ScienceOn
26 McGrath J, Solter D : completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37 : 179, 1984   DOI   ScienceOn
27 Chalitchagorn K, Shuangshoti S, Hourpai N et al : Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23 : 8841, 2004   DOI   ScienceOn
28 Jaenisch R, Bird A : Epigenetic reulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 suppl : 245, 2003   DOI   ScienceOn
29 Constancia M : Resourceful imprinting. Nature 432(7013) : 53, 2004   DOI   ScienceOn
30 IIsles, AR, Holland AJ : Imprinted genes and mother-offspring interactions. Early Hum Dev 81(1) : 73, 2005   DOI   ScienceOn
31 Park HJ, Yu E. Shim YH : DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Cancer Lett 233 : 271, 2006   DOI   ScienceOn
32 Maruyama R, Sugio K, Yoshino K et al : Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Cancer 100 : 1472, 2004   DOI   ScienceOn
33 Singai R, Ginder GD : DNA methylation. Blood 93 : 4059, 1999   PUBMED
34 Okano M, Bell DW, Haber DA et al : DNA methyltransferase Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99 : 247, 1999   DOI   ScienceOn
35 Ishida E, Nakamura M, Ikuta M et al : Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Oral Oncol 41 : 614, 2005   DOI   ScienceOn
36 Chen T, Ueda Y, Xie S : A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its exression correlates with active de novo methylation. J Biol Chem 277 : 38746, 2002   DOI   ScienceOn
37 Ponger L : Determinants of CpG islands : expression in early embryo and isochore structure. Genome Res 11 : 1854, 2001   PUBMED
38 Sved J, Bird A : The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci USA 87 : 4692, 1990
39 Dallosso AR, Hancock AL, Moorwood K et al : Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in wilms tumors. Hum Mol Genet 13 : 405, 2004   DOI   ScienceOn
40 Xie S, Wang Z, Okano M et al : Cloning, expression and chromosome location of the human DNMT3 gene family. Gene 236 : 87, 1999   DOI   ScienceOn
41 Li S, Rong M, Iacopetta B : DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett 18 : 272, 2005
42 Hata K, Okano M, Lei H et al : Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to etablish maternal imprints in mice. Development 129 : 1983, 2002
43 Lee S, Hwang KS, Lee HJ et al : Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84 : 884, 2004   DOI   ScienceOn
44 Miranda TB, Johnes PA : DNA methylation: the nuts and bolts of repression. J Cell Physiol 213 : 384, 2007   DOI   ScienceOn
45 Bestor T, Laudano A, Mattaliano R et al : Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes in related to bacterial restriction methyltransferase. J Mol Biol 203 : 971, 1988   DOI
46 Wong TS, Man MW, Lam AK et al : The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer 39 : 1881, 2003   DOI   ScienceOn
47 Tycko B, Morison JM : Physiological functions of imprinted genes. J Cell Physiol 192 : 245, 2002   DOI   ScienceOn
48 Puri SK, Si L, Fan CY et al : Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26 : 12, 2005   DOI   ScienceOn